March 26, 2024
Eisai said on March 25 that it has reached a settlement with Indian drug maker Sun Pharmaceutical Industries over a patent infringement lawsuit involving a generic version of its cancer drug Lenvima (lenvatinib) in the US. The Japanese pharma has...read more